Quantitative Echocardiographic Determinants of Clinical Outcome in Asymptomatic Patients With Aortic RegurgitationA Prospective Study
Delphine Detaint, MD,
David Messika-Zeitoun, MD,
Joseph Maalouf, MD,
Christophe Tribouilloy, MD,
Douglas W. Mahoney, MS,
A. Jamil Tajik, MD, FACC,
Maurice Enriquez-Sarano, MD, FACC*
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota.
* Reprint requests and correspondence: Dr. Maurice Enriquez-Sarano, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. (Email: Sarano.maurice{at}mayo.edu).
Objectives: The purpose of this study was to define the link between aortic regurgitation (AR) quantitation and clinical outcome in asymptomatic patients with AR.
Background: Quantitative American Society of Echocardiography (QASE) thresholds are recommended for AR assessment, but impact on clinical outcome is unknown.
Methods: We prospectively enrolled (1991 to 2003) 251 asymptomatic patients (age 60 ± 17 years) with isolated AR and ejection fraction 50% with quantified AR and left ventricular (LV) volumes using Doppler-echocardiography.
Results: Survival under medical management was independently determined by baseline regurgitant volume (RVol) (adjusted hazard ratio [HR] 1.22 [95% confidence interval (CI) 1.08 to 1.35] per 10 ml/beat, p = 0.002) and effective regurgitant orifice (ERO) (adjusted HR 1.52 [95% CI 1.19 to 1.91] per 10 mm2, p = 0.002), which superseded traditional AR grading. Patients with QASE-severe AR (RVol 60 ml/beat or ERO 30 mm2) versus QASE-mild AR (RVol <30 ml and ERO <10 mm2) had lower survival (10 years: 69 ± 9% vs. 92 ± 4%, p = 0.05) independently of all clinical characteristics (adjusted HR 4.1 [95% CI 1.4 to 14.1], p = 0.01) and lower survival free of surgery for AR (10 years: 20 ± 5% vs. 92 ± 4%, p < 0.001, adjusted HR 12.9 [95% CI 5.4 to 38.5]). Cardiac events were considerably more frequent with QASE-severe versus -moderate or -mild AR (10 years: 63 ± 8% vs. 34 ± 6% and 21 ± 8%, p < 0.0001). Independent determinants of cardiac events were quantitative AR grading (QASE-severe adjusted HR 5.2 [95% CI 2.2 to 14.8], p < 0.001; QASE-moderate adjusted HR 2.4 [95% CI 1.06 to 6.6], p = 0.035), which superseded traditional AR assessment (p < 0.001) and LV end-systolic volume index (ESVI) (adjusted HR 1.09 [95% CI 1.03 to 1.14 per 10 ml/m2], p = 0.002), which superseded LV M-mode diameters. In QASE-severe AR, patients with ESVI 45 versus <45 ml/m2 had higher cardiac event rates (10 years: 87 ± 8% vs. 40 ± 10%, p < 0.001). Cardiac surgery for AR reduced cardiac events in patients with QASE-severe AR (adjusted HR 0.23 [95% CI 0.09 to 0.57], p = 0.002).
Conclusions: Echocardiographic quantitation of AR severity and ESVI provides independent and superior predictors of clinical outcome in asymptomatic patients with AR and ejection fraction 50% and should be widely clinically applied. Patients with QASE-severe AR and ESVI 45 ml/m2 should be carefully considered for cardiac surgery, which reduces cardiac events risk.
|
Abbreviations and Acronyms
| | AR = aortic regurgitation | | EF = ejection fraction | | ERO = effective regurgitant orifice | | ESVI = end-systolic volume index | | LV = left ventricle/ventricular | | QASE = quantitative American Society of Echocardiography | | RVol = regurgitant volume |
|
Related articles in JACC Imaging:
- Cardiologists: Do We Have the Right to Call Ourselves Physiologists?
- Blase A. Carabello
JACC Imaging 2008 1: 12-14.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol.,
May 19, 2009;
53(20):
1894 - 1908.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Detaint, J. Maalouf, C. Tribouilloy, D. W. Mahoney, H. V. Schaff, A. J. Tajik, and M. Enriquez-Sarano
Congestive heart failure complicating aortic regurgitation with medical and surgical management: a prospective study of traditional and quantitative echocardiographic markers.
J. Thorac. Cardiovasc. Surg.,
December 1, 2008;
136(6):
1549 - 1557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Heidenreich
Is quantitation a good value?
J. Am. Coll. Cardiol. Img.,
May 1, 2008;
1(3):
404 - 404.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enriquez-Sarano
Reply.
J. Am. Coll. Cardiol. Img.,
May 1, 2008;
1(3):
404 - 405.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Carabello
Cardiologists: do we have the right to call ourselves physiologists?
J. Am. Coll. Cardiol. Img.,
January 1, 2008;
1(1):
12 - 14.
[Full Text]
[PDF]
|
 |
|
|